{"id":"W2622171693","doi":"10.1002/hon.2438_45","title":"END OF TREATMENT <scp>PET‐CT</scp> PREDICTS PROGRESSION‐FREE SURVIVAL IN <scp>DLBCL</scp> AFTER FIRST‐LINE TREATMENT: RESULTS FROM THE PHASE III <scp>GOYA</scp> STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta","funders":"","keywords":"Medicine; Nuclear medicine; Internal medicine; Clinical endpoint; Rituximab; PET-CT; Diffuse large B-cell lymphoma; Progression-free survival; CHOP; Phases of clinical research; Oncology; Clinical trial; Positron emission tomography; Lymphoma; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008459206,0.001150409,0.003241519,0.000215113,0.0006143211,0.0001127429,0.000952629,0.0004389235,0.00007171316],"category_scores_gemma":[0.006909384,0.0006193659,0.0006532992,0.0003010213,0.001026983,0.0001955749,0.0006824121,0.0004303714,0.0001499779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00139364,"about_ca_system_score_gemma":0.000679615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001878061,"about_ca_topic_score_gemma":0.00539537,"domain_scores_codex":[0.9931125,0.0008095013,0.002008142,0.00175664,0.0008955117,0.00141768],"domain_scores_gemma":[0.9815899,0.01313609,0.001394447,0.002925404,0.0002262879,0.0007279118],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001283765,0.09581637,0.8314591,0.00007349034,0.002040602,0.04020061,0.006797931,0.00001296458,0.00008768127,0.0003911592,0.007239944,0.0145964],"study_design_scores_gemma":[0.188179,0.04989938,0.6505668,0.0005485003,0.002458412,0.001249681,0.005119022,0.0002443634,0.006524437,0.0008218859,0.09423652,0.0001520479],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779856,0.003021376,0.000005471232,0.001877792,0.0007087689,0.005028853,0.001017887,0.0001834932,0.01017078],"genre_scores_gemma":[0.9919388,0.001845069,0.0005258555,0.0002762573,0.0004482295,0.003034456,0.0004610131,0.0000770187,0.001393273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1868952,"threshold_uncertainty_score":0.9996257,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05398042620619866,"score_gpt":0.3550490730967307,"score_spread":0.3010686468905321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}